Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
BYRN
Deeply undervalued
Byrna Technologies Inc.
Price$4.52
Model IV$15.80
P/IV0.26
Discount 71%
Return to IV: +249.6%
Market implies -22.9%/yr
vs model +29.4% · below model
BYSI
Valuation N/A
BeyondSpring Inc.
Price$0.61
Model IV—
P/IV—
Market implies +34.0%/yr
BZAI
Overvalued
Blaize Holdings, Inc.
Price$0.29
Model IV$0.24
P/IV2.42
Premium +24%
Return to IV: -19.1%
Market implies +7.0%/yr
vs model +15.0% · below model
BZAIW
Deeply undervalued
Blaize Holdings, Inc.
Price$0.04
Model IV$0.21
P/IV0.53
Discount 82%
Return to IV: +454.1%
Market implies -37.5%/yr
vs model +15.0% · below model
BZFD
Deeply undervalued
BuzzFeed, Inc.
Price$1.19
Model IV$1.97
P/IV0.62
Discount 39%
Return to IV: +65.1%
Market implies -9.4%/yr
vs model +2.0% · below model
BZFDW
Valuation N/A
BuzzFeed, Inc.
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +2.0% · below model
BZUN
Deeply undervalued
Baozun Inc.
Price$3.31
Model IV$4.99
P/IV0.60
Discount 34%
Return to IV: +50.7%
Market implies -4.1%/yr
vs model +5.3% · below model
CAAS
Overvalued
China Automotive Systems, Inc.
Price$4.48
Model IV$3.82
P/IV1.14
Premium +17%
Return to IV: -14.8%
Market implies +6.4%/yr
vs model +8.0% · in line
CABO
Valuation N/A
Cable One, Inc.
Price$11.14
Model IV—
P/IV—
Market implies -50.0%/yr
CABR
Valuation N/A
Caring Brands, Inc.
Price$1.16
Model IV—
P/IV—
Market implies +145.4%/yr
CAF
Valuation N/A
Morgan Stanley China A Share Fund, Inc.
Price$17.20
Model IV—
P/IV—
Limited data — see page
CAIIU
Valuation N/A
Collective Acquisition Corp. II
Price$10.05
Model IV—
P/IV—
Limited data — see page
CALC
Valuation N/A
CalciMedica, Inc.
Price$1.27
Model IV—
P/IV—
Limited data — see page
CAMP
Valuation N/A
Camp4 Therapeutics Corp
Price$3.77
Model IV—
P/IV—
Market implies +25.4%/yr
CANF
Valuation N/A
Can-Fite BioPharma Ltd.
Price$1.90
Model IV—
P/IV—
Market implies +27.1%/yr
CANG
Valuation N/A
Cango Inc.
Price$3.51
Model IV—
P/IV—
Market implies +67.4%/yr
vs model +2.8% · above model
CAPN
Valuation N/A
Cayson Acquisition Corp
Price$11.27
Model IV—
P/IV—
Limited data — see page
CAPNR
Valuation N/A
Cayson Acquisition Corp
Price$0.08
Model IV—
P/IV—
Limited data — see page
CAPNU
Valuation N/A
Cayson Acquisition Corp
Price$12.50
Model IV—
P/IV—
Limited data — see page
CAPS
Valuation N/A
Capstone Holding Corp.
Price$0.14
Model IV—
P/IV—
Market implies -50.0%/yr
CAQ
Valuation N/A
Cambridge Acquisition Corp.
Price$10.00
Model IV—
P/IV—
Limited data — see page
CAQUU
Valuation N/A
Cambridge Acquisition Corp.
Price$10.07
Model IV—
P/IV—
Limited data — see page
CAQUW
Valuation N/A
Cambridge Acquisition Corp.
Price$0.32
Model IV—
P/IV—
Limited data — see page
CAST
Valuation N/A
FreeCast, Inc.
Price$1.16
Model IV—
P/IV—
Market implies +68.4%/yr
CATO
Valuation N/A
CATO CORP
Price$2.47
Model IV—
P/IV—
Market implies -35.2%/yr
vs model +2.0% · below model
CBAT
Valuation N/A
CBAK Energy Technology Ltd
Price$1.05
Model IV—
P/IV—
Limited data — see page
CBFV
Deeply overvalued
CB Financial Services, Inc.
Price$37.20
Model IV$23.09
P/IV1.64
Premium +61%
Return to IV: -37.9%
CBUS
Valuation N/A
Cibus, Inc.
Price$1.55
Model IV—
P/IV—
Market implies +47.9%/yr
vs model +5.0% · above model
CCD
Valuation N/A
Calamos Dynamic Convertible & Income Fund
Price$24.38
Model IV—
P/IV—
Limited data — see page
CCEL
Deeply undervalued
CRYO CELL INTERNATIONAL INC
Price$4.36
Model IV$6.88
P/IV0.61
Discount 37%
Return to IV: +57.7%
Market implies -4.5%/yr
vs model +7.7% · below model
CCGWW
Valuation N/A
Cheche Group Inc.
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +11.7% · below model
CCHH
Valuation N/A
CCH Holdings Ltd
Price$0.99
Model IV—
P/IV—
Market implies +10.4%/yr
CCID
Valuation N/A
Carlyle Credit Income Fund
Price$24.82
Model IV—
P/IV—
Limited data — see page
CCIF
Valuation N/A
Carlyle Credit Income Fund
Price$2.35
Model IV—
P/IV—
Limited data — see page
CCII
Valuation N/A
Cohen Circle Acquisition Corp. II
Price$10.29
Model IV—
P/IV—
Limited data — see page
CCIIU
Valuation N/A
Cohen Circle Acquisition Corp. II
Price$10.46
Model IV—
P/IV—
Limited data — see page
CCIIW
Valuation N/A
Cohen Circle Acquisition Corp. II
Price$0.47
Model IV—
P/IV—
Limited data — see page
CCIX
Valuation N/A
CCIX
Price$10.88
Model IV—
P/IV—
Limited data — see page
CCIXU
Valuation N/A
CCIXU
Price$10.81
Model IV—
P/IV—
Limited data — see page
CCIXW
Valuation N/A
CCIXW
Price$0.00
Model IV—
P/IV—
Limited data — see page
CCLD
Deeply undervalued
CareCloud, Inc.
Price$2.00
Model IV$7.52
P/IV0.29
Discount 73%
Return to IV: +276.1%
Market implies -17.4%/yr
vs model +7.3% · below model
CCTG
Valuation N/A
CCSC Technology International Holdings Ltd
Price$0.50
Model IV—
P/IV—
Market implies -27.9%/yr
CCXI
Valuation N/A
Churchill Capital Corp XI
Price$10.93
Model IV—
P/IV—
Limited data — see page
CCXIU
Valuation N/A
Churchill Capital Corp XI
Price$11.70
Model IV—
P/IV—
Limited data — see page
CCXIW
Valuation N/A
Churchill Capital Corp XI
Price$4.88
Model IV—
P/IV—
Limited data — see page
CDIO
Valuation N/A
Cardio Diagnostics Holdings, Inc.
Price$1.87
Model IV—
P/IV—
Market implies +64.6%/yr
CDIOW
Deeply undervalued
Cardio Diagnostics Holdings, Inc.
Price$0.01
Model IV$0.03
P/IV0.33
Discount 67%
Return to IV: +200.0%
Market implies -25.0%/yr
vs model +50.0% · below model
CDLX
Fairly valued
Cardlytics, Inc.
Price$2.06
Model IV$2.24
P/IV1.60
Discount 8%
Return to IV: +8.9%
Market implies +2.7%/yr
vs model +2.0% · in line
CDROW
Valuation N/A
Codere Online Luxembourg, S.A.
Price$0.17
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +28.2% · below model
CDT
Valuation N/A
CDT Equity Inc.
Price$0.72
Model IV—
P/IV—
Limited data — see page
CDTG
Valuation N/A
CDT Environmental Technology Investment Holdings Ltd
Price$1.22
Model IV—
P/IV—
Limited data — see page
CDTTW
Valuation N/A
CDT Equity Inc.
Price$0.01
Model IV—
P/IV—
Limited data — see page
CDXS
Valuation N/A
CODEXIS, INC.
Price$1.41
Model IV—
P/IV—
Market implies +45.7%/yr
vs model +0.7% · above model
CDZI
Deeply overvalued
CADIZ INC
Price$3.42
Model IV$0.78
P/IV4.37
Premium +337%
Return to IV: -77.1%
CEE
Valuation N/A
CENTRAL & EASTERN EUROPE FUND, INC.
Price$18.17
Model IV—
P/IV—
Limited data — see page
CELU
Deeply overvalued
Celularity Inc
Price$1.56
Model IV$0.38
P/IV4.08
Premium +308%
Return to IV: -75.5%
Market implies +20.5%/yr
vs model +5.6% · above model
CELUW
Valuation N/A
CELUW
Price$0.00
Model IV—
P/IV—
Limited data — see page
CELZ
Valuation N/A
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Price$0.84
Model IV—
P/IV—
Market implies +80.4%/yr
CENN
Valuation N/A
Cenntro Inc.
Price$3.71
Model IV—
P/IV—
Market implies +59.1%/yr
vs model +6.9% · above model
CEPF
Valuation N/A
Cantor Equity Partners IV, Inc.
Price$10.27
Model IV—
P/IV—
Limited data — see page
